Adicet Bio, Inc.
ACET
$0.537
$0.089920.11%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 17.90% | 17.59% | -19.22% | -32.77% | -104.41% |
| Total Depreciation and Amortization | 6.07% | 19.50% | 43.76% | 86.80% | 136.82% |
| Total Amortization of Deferred Charges | 30.00% | -61.17% | -59.80% | -42.86% | -67.39% |
| Total Other Non-Cash Items | -44.17% | -37.37% | 115.59% | 119.26% | 116.99% |
| Change in Net Operating Assets | -2,292.46% | -202.05% | -176.31% | -133.04% | -90.82% |
| Cash from Operations | 1.43% | -3.03% | -9.42% | -26.74% | -109.35% |
| Capital Expenditure | 74.96% | 90.04% | 89.25% | 82.65% | 73.40% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2,571.19% | 90.04% | 89.25% | 82.65% | 73.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 53,689.64% | 8,441.61% | 148.50% | 147.67% | -99.14% |
| Repurchase of Common Stock | -64,114.00% | -11,349.17% | 86.86% | 86.86% | 95.36% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 47,063.98% | 3,146.98% | 160.40% | 160.83% | -99.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.42% | 21.77% | 133.72% | 134.38% | -388.80% |
